Researchers Chafe at Halt of Psychiatric Trials

March 31, 2015

(Nature) – University of Minnesota psychiatrist Kathryn Cullen had just started recruiting volunteers for the first clinical trial of the anaesthetic ketamine against treatment-resistant depression in adolescents when the university’s administration stopped the study in its tracks. On 18 March she received a surprising letter from the university president announcing that he was “suspending enrollment in all Department of Psychiatry interventional drug studies currently active or awaiting approval.”